Targeting biomolecules with reversible covalent chemistry
- PMID: 27599186
- PMCID: PMC5107367
- DOI: 10.1016/j.cbpa.2016.08.011
Targeting biomolecules with reversible covalent chemistry
Abstract
Interaction of biomolecules typically proceeds in a highly selective and reversible manner, for which covalent bond formation has been largely avoided due to the potential difficulty of dissociation. However, employing reversible covalent warheads in drug design has given rise to covalent enzyme inhibitors that serve as powerful therapeutics, as well as molecular probes with exquisite target selectivity. This review article summarizes the recent advances in the development of reversible covalent chemistry for biological and medicinal applications. Specifically, we document the chemical strategies that allow for reversible modification of the three major classes of nucleophiles in biology: thiols, alcohols and amines. Emphasis is given to the chemical mechanisms that underlie the development of these reversible covalent reactions and their utilization in biology.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures
References
-
- Dansen TB, Smits LMM, van Triest MH, de Keizer PLJ, van Leenen D, Koerkamp MG, Szypowska A, Meppelink A, Brenkman AB, Yodoi J, Holstege FCP, Burgering BMT. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat Chem Biol. 2009;5:664–672. - PubMed
-
- Singh J, Petter RC, Baillie TA, Whitty A. The resurgence of covalent drugs. Nat Rev Drug Discov. 2011;10:307–317. This article presents a detailed and systematic analysis of covalent drugs in comparison to their noncovalent counterparts. - PubMed
-
- Uetrecht J. Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol. 2008;21:84–92. - PubMed
-
- Pace NJ, Weerapana E. Diverse functional roles of reactive cysteines. ACS Chem Biol. 2013;8:283–296. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
